282 related articles for article (PubMed ID: 12167711)
1. Hypophosphorylation of Mdm2 augments p53 stability.
Blattner C; Hay T; Meek DW; Lane DP
Mol Cell Biol; 2002 Sep; 22(17):6170-82. PubMed ID: 12167711
[TBL] [Abstract][Full Text] [Related]
2. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
4. MDM2 promotes ubiquitination and degradation of MDMX.
Pan Y; Chen J
Mol Cell Biol; 2003 Aug; 23(15):5113-21. PubMed ID: 12860999
[TBL] [Abstract][Full Text] [Related]
5. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
6. The MDM2-p53 interaction.
Moll UM; Petrenko O
Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.
Hjerrild M; Milne D; Dumaz N; Hay T; Issinger OG; Meek D
Biochem J; 2001 Apr; 355(Pt 2):347-56. PubMed ID: 11284721
[TBL] [Abstract][Full Text] [Related]
8. Critical role for a central part of Mdm2 in the ubiquitylation of p53.
Meulmeester E; Frenk R; Stad R; de Graaf P; Marine JC; Vousden KH; Jochemsen AG
Mol Cell Biol; 2003 Jul; 23(14):4929-38. PubMed ID: 12832478
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase.
Lin HK; Wang L; Hu YC; Altuwaijri S; Chang C
EMBO J; 2002 Aug; 21(15):4037-48. PubMed ID: 12145204
[TBL] [Abstract][Full Text] [Related]
10. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
Fang S; Jensen JP; Ludwig RL; Vousden KH; Weissman AM
J Biol Chem; 2000 Mar; 275(12):8945-51. PubMed ID: 10722742
[TBL] [Abstract][Full Text] [Related]
11. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Wang W; Takimoto R; Rastinejad F; El-Deiry WS
Mol Cell Biol; 2003 Mar; 23(6):2171-81. PubMed ID: 12612087
[TBL] [Abstract][Full Text] [Related]
13. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
Xirodimas D; Saville MK; Edling C; Lane DP; LaĆn S
Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
[TBL] [Abstract][Full Text] [Related]
14. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
15. MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.
Jin Y; Lee H; Zeng SX; Dai MS; Lu H
EMBO J; 2003 Dec; 22(23):6365-77. PubMed ID: 14633995
[TBL] [Abstract][Full Text] [Related]
16. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.
Ito A; Kawaguchi Y; Lai CH; Kovacs JJ; Higashimoto Y; Appella E; Yao TP
EMBO J; 2002 Nov; 21(22):6236-45. PubMed ID: 12426395
[TBL] [Abstract][Full Text] [Related]
17. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
18. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
[TBL] [Abstract][Full Text] [Related]
19. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
Honda R; Yasuda H
EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]